Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $18.63 and traded as low as $18.25. Pro-Dex shares last traded at $18.49, with a volume of 6,110 shares trading hands.
Analyst Ratings Changes
Separately, StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, June 5th.
View Our Latest Stock Analysis on PDEX
Pro-Dex Stock Performance
Pro-Dex (NASDAQ:PDEX – Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.19 EPS for the quarter. The company had revenue of $14.29 million for the quarter. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%.
Institutional Investors Weigh In On Pro-Dex
An institutional investor recently raised its position in Pro-Dex stock. Perritt Capital Management Inc. lifted its stake in shares of Pro-Dex, Inc. (NASDAQ:PDEX – Free Report) by 43.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,000 shares of the medical instruments supplier’s stock after purchasing an additional 1,813 shares during the period. Perritt Capital Management Inc. owned about 0.18% of Pro-Dex worth $106,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 15.28% of the company’s stock.
About Pro-Dex
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Further Reading
- Five stocks we like better than Pro-Dex
- What is a Bond Market Holiday? How to Invest and Trade
- The Top 3 Sectors Poised For Growth This Summer
- Comparing and Trading High PE Ratio Stocks
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- 3 Healthcare Dividend Stocks to Buy
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.